4th Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Small Business SMB

H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to small business tax provisions; H.R. 1166 (E-Fencing Enforcement Act of 2009), H.R. 1173 (Organized Retail Crime Act of 2009) and S. 470 (Combating Organized Retail Crime Act of 2009); H.R. 3200, "America's Affordable Health Choices Act of 2009", and Senate version of H.R. 3590, "The Patient Protection and Affordable Care Act, requirements for businesses to provide health insurance to employees.

LobbyistCovered position, as disclosed
ANNE CASSITY —
JOHN M COSTER —
STEPHEN M COTE —
ADNAN JALIL —
TONY S LEE —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Treasury, Dept of; Drug Enforcement Administration (DEA); Congressional Budget Office (CBO); SENATE; Food & Drug Administration (FDA); Small Business Administration (SBA)

Bills named: H.R. 1173 (111th), H.R. 1166 (111th), H.R. 3590 (111th), H.R. 3200 (111th), S. 470 (111th), H.R. 1 (111th)

Pharmacy PHA

H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 110th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; and Sec. 172, related to submission of claims by pharmacies located in or contracting with long-term care facilities; Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements; H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009, pharmacy provider provisions; S. 1383, the "Dextromethorphan Abuse Reduction Act; H.R.3763: To amend the Fair Credit Reporting Act to provide for an exclusion from Red Flag Guidelines for certain businesses, pharmacy provision; H.R.3663: To amend title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies; H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy management, public plan option and pharmacy benefit manager transparency requirements; H.R.3590: An act entitled The Patient Protection and Affordable Care ActDME Accreditation, AMP Fix, PBM Transparency, MTM Expansion, OPM PBA v. PBM; Senator Akaka Amendment to Senate version of H.R. 3590 to establish automatic enrollment into a Medicare Part D "chronic care management" program for targeted individuals; Senator Brown amendment to H.R. 3590 eliminating DMEPOS surety bond requirement for retail pharmacies; Senator Dorgan Drug Reimportation amendment to H.R. 3590; FSA Debit Card Programseeking Congressional support to amend IRS guidance (no legislation).

LobbyistCovered position, as disclosed
ANNE CASSITY —
JOHN M COSTER —
STEPHEN M COTE —
ADNAN JALIL —
TONY S LEE —

Contacted: Treasury, Dept of; Small Business Administration (SBA); Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Congressional Budget Office (CBO); Drug Enforcement Administration (DEA)

Bills named: S. 1390 (111th), H.R. 6331 (111th), H.R. 2647 (111th), S. 1383 (111th), S. 956 (111th), H.R. 3590 (111th), H.R. 5839 (111th), S. 1649 (111th), H.R. 3108 (111th), H.R. 3200 (111th), H.R. 2891 (111th), S. 2161 (111th), H.R. 1204 (111th), S. 511 (111th), H.R. 1970 (111th), H.R. 616 (111th), H.R. 3663 (111th), H.R. 3763 (111th), H.R. 1 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.